Incyte Genomics, Inc. (INCY) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $127.62 +2.30%
EPS Growth %: -225.2%
Financial Fact:
Income (loss) before income taxes: 38.3M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -225.2%
Financial Fact:
Income (loss) before income taxes: 38.3M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Incyte Genomics, Inc. (NASDAQ: INCY) reported Q3 loss of ($0.42), $0.03 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $16.54 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald as Opzelura Attractive in HS
- Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald After Management Chat
- RH (RH) Tops Q2 EPS by $2.31
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
